The 2 analysts offering 12-month price forecasts for Neuroone Medical Technologies Corp have a median target of 2.10, with a high estimate of 2.20 and a low estimate of 2.00. The median estimate represents a +128.01% increase from the last price of 0.92.
The current consensus among 2 polled investment analysts is to Buy stock in Neuroone Medical Technologies Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.15
Reporting Date Dec 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.